- Home
- RSVR vs CYRX Comparison
RSVR vs CYRX Comparison
Compare RSVR & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSVR
- CYRX
- Stock Information
- Founded
- RSVR 2007
- CYRX 1999
- Country
- RSVR United States
- CYRX United States
- Employees
- RSVR N/A
- CYRX N/A
- Industry
- RSVR Movies/Entertainment
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- RSVR Consumer Discretionary
- CYRX Health Care
- Exchange
- RSVR Nasdaq
- CYRX Nasdaq
- Market Cap
- RSVR 498.2M
- CYRX 438.7M
- IPO Year
- RSVR N/A
- CYRX N/A
- Fundamental
- Price
- RSVR $7.34
- CYRX $8.45
- Analyst Decision
- RSVR Strong Buy
- CYRX Strong Buy
- Analyst Count
- RSVR 1
- CYRX 9
- Target Price
- RSVR $11.50
- CYRX $12.83
- AVG Volume (30 Days)
- RSVR 61.8K
- CYRX 868.3K
- Earning Date
- RSVR 11-04-2025
- CYRX 11-04-2025
- Dividend Yield
- RSVR N/A
- CYRX N/A
- EPS Growth
- RSVR N/A
- CYRX N/A
- EPS
- RSVR 0.15
- CYRX 1.27
- Revenue
- RSVR $166,320,844.00
- CYRX $243,795,000.00
- Revenue This Year
- RSVR $7.17
- CYRX N/A
- Revenue Next Year
- RSVR $5.00
- CYRX $9.20
- P/E Ratio
- RSVR $50.10
- CYRX $6.63
- Revenue Growth
- RSVR 11.17
- CYRX 27.69
- 52 Week Low
- RSVR $6.56
- CYRX $4.58
- 52 Week High
- RSVR $9.83
- CYRX $11.44
- Technical
- Relative Strength Index (RSI)
- RSVR 43.38
- CYRX 39.16
- Support Level
- RSVR $7.28
- CYRX $8.95
- Resistance Level
- RSVR $7.57
- CYRX $9.59
- Average True Range (ATR)
- RSVR 0.22
- CYRX 0.66
- MACD
- RSVR 0.00
- CYRX -0.20
- Stochastic Oscillator
- RSVR 27.87
- CYRX 10.44
About RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. It operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the Music Publishing segment.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.